panobinostat (MTX110) / Biodexa Pharma  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
panobinostat (MTX110) / Biodexa Pharma
PNOC015, NCT03566199: MTX110 by Convection-Enhanced Delivery in Treating Participants With Newly-Diagnosed Diffuse Intrinsic Pontine Glioma

Completed
1/2
7
US
Panobinostat Nanoparticle Formulation MTX110, MTX-110, MTX110 (CN), Convection-Enhanced Delivery (CED), CED
Sabine Mueller, MD, PhD, Midatech Pharma US Inc., Pacific Pediatric Neuro-Oncology Consortium
Diffuse Intrinsic Pontine Glioma
03/21
03/21

Download Options